Related Experiment Videos
[Arteriosclerosis obliterans]
M Kitatani1, H Mabuchi, K Ueda
1Second Department of Internal Medicine, Kanazawa University School of Medicine.
Insights
Arteriosclerosis obliterans (ASO) is a significant health issue for elderly Japanese individuals. Recent advancements offer improved diagnostic and treatment options, including minimally invasive procedures and LDL-apheresis.
Area of Science:
- Vascular Medicine
- Geriatric Health
- Cardiovascular Research
Context:
- Arteriosclerosis obliterans (ASO) presents a growing health challenge, particularly among the elderly population in Japan.
- ASO is a systemic condition often coexisting with other atherosclerotic diseases, impacting cerebrovascular, coronary, and renal systems.
- The comprehensive management of ASO requires consideration of the patient's overall health status and quality of life.
Purpose:
- To review recent advancements in the diagnosis and treatment of Arteriosclerosis Obliterans (ASO).
- To highlight the development of various medical and surgical therapeutic strategies for ASO.
- To emphasize the importance of a holistic approach in managing ASO patients.
Summary:
- Recent progress in ASO diagnosis and treatment is reviewed, focusing on innovative medical and surgical interventions.
- Advanced treatments include atherectomy catheters, endovascular metallic stenting, laser angioplasty, and LDL-apheresis.
- Effective ASO management necessitates a thorough evaluation of the patient's complete medical profile and quality of life.
Impact:
- Improved diagnostic accuracy and therapeutic efficacy for Arteriosclerosis Obliterans.
- Enhanced treatment options for elderly patients with ASO, potentially improving outcomes.
- Greater consideration for patient quality of life in ASO treatment planning.
Abstract:
Arteriosclerosis obliterans (ASO) has become one of major health problems in the elderly people in Japan. This paper reviews the recent progress in the diagnosis and treatment of ASO. Both medical and surgical treatments, such as atherectomy catheters, endovascular metallic stenting, laser angioplasty and LDL-apheresis have recently been greatly developed. As atherosclerosis is a generalised disease, patients with ASO tend to have other atherosclerotic diseases, i.e., cerebrovascular disease, coronary heart disease and renal vascular disease. For the selection of treatments, we have to consider the whole background of the patients, including a quality of life.